NFL Biosciences SAS (ALNFL) — Cash Flow-to-Debt Ratio
Latest as of June 2023:
0.02x
NFL Biosciences SAS (ALNFL) has a Cash Flow-to-Debt Ratio of 0.02x as of June 2023, meaning its operating cash flow of €57.51K could theoretically repay 0% of its total liabilities (€3.67 Million) in one year. See ALNFL free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
0.02x
Operating CF / Total Liabilities
Operating Cash Flow
€57.51K
EUR
Total Liabilities
€3.67 Million
EUR
Data as of
Jun 2023
Most recent filing
NFL Biosciences SAS Cash Flow-to-Debt Ratio (2020–2022)
Historical debt coverage capacity for NFL Biosciences SAS across 3 annual periods. For the full cash flow conversion analysis, see ALNFL operating cash flow.
Annual Cash Flow-to-Debt Ratio for NFL Biosciences SAS (2020–2022)
Year-by-year debt coverage analysis for NFL Biosciences SAS.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2022 | 0.07x | €104.89K | €1.55 Million | ▼ -69.1% |
| 2021 | 0.22x | €87.00K | €397.73K | ▲ +11.2% |
| 2020 | 0.20x | €83.91K | €426.61K | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.